Although the first anti-depressants were developed more than 70 years ago based on brain chemistry, we still don’t really understand the disease. Some people get better; many don’t.
To Silicon Valley, the answer to solving depression is data. After all, most anti-depressant trials only recruit up to thousands of people. With digital health, anyone with a wrist wearable or smartphone could potentially contribute in the largest studies ever attempted by mankind.
Will the data one day be used in a dystopian-like society, where insurance companies track their customers’ mental health status or people receive unwanted ads tailored to mood downswings?MORE